Exhibit 99.A

 

EXHIBIT A

 

JOINT FILING AGREEMENT

 

In accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, the undersigned agree to the joint filing on behalf of each of them of a statement on Schedule 13G (including amendments thereto) with respect to the Common Stock of Relmada Therapeutics, Inc. and further agree that this agreement be included as an exhibit to such filing. Each party to the agreement expressly authorizes each other party to file on its behalf any and all amendments to such statement. Each party to this agreement agrees that this joint filing agreement may be signed in counterparts.

 

In evidence whereof, the undersigned have caused this Agreement to be executed on their behalf this 16th day of December, 2019.

 

Venrock Healthcare Capital Partners II, L.P.

 

Venrock Healthcare Capital Partners III, L.P.

 

 

 

By:

VHCP Management II, LLC

 

By:

VHCP Management III, LLC

Its:

General Partner

 

Its:

General Partner

 

 

 

 

 

By:

/s/ David L. Stepp

 

By:

/s/ David L. Stepp

 

Name:

David L. Stepp

 

 

Name:

David L. Stepp

 

Its:

Authorized Signatory

 

 

Its:

Authorized Signatory

 

 

 

VHCP Co-Investment Holdings II, LLC

 

VHCP Co-Investment Holdings III, LLC

 

 

 

By:

VHCP Management II, LLC

 

By:

VHCP Management III, LLC

Its:

Manager

 

Its:

Manager

 

 

 

 

 

By:

/s/ David L. Stepp

 

By:

/s/ David L. Stepp

 

Name:

David L. Stepp

 

 

Name:

David L. Stepp

 

Its:

Authorized Signatory

 

 

Its:

Authorized Signatory

 

 

 

 

VHCP Management II, LLC

 

VHCP Management III, LLC

 

 

 

By:

/s/ David L. Stepp

 

By:

/s/ David L. Stepp

 

Name:

David L. Stepp

 

 

Name:

David L. Stepp

 

Its:

Authorized Signatory

 

 

Its:

Authorized Signatory

 

 

 

Nimish Shah

 

Bong Koh

 

 

 

By:

/s/ David L. Stepp

 

By:

/s/ David L. Stepp

 

David L. Stepp, as attorney-in-fact

 

 

David L. Stepp, as attorney-in-fact